An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism

Tumor Biology

Volumn 37, Issue 12, 2016, Pages 15795-15804

  Luo, Jingtao ^a,b   Hong, Yun ^b,c   Tao, Xiaoan ^b,c   Wei, Xi ^a,d   Zhang, Lun ^a   Li, Qiang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

CPT 1a; Energy stress; Fatty acid metabolism; Warburg effect

Indexed keywords

ADENYLATE KINASE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE IA; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIPID STORAGE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION REACTION; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR ESCAPE; TUMOR VOLUME; UPREGULATION;

EID: 84991049612     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-5382-6     Document Type: Article

References (26)

1. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95.
2. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23:537–48.
3. Romero-Garcia S, Lopez-Gonzalez JS, Baez-Viveros JL, Aguilar-Cazares D, Prado-Garcia H. Tumor cell metabolism: an integral view. Cancer Biology & Therapy. 2011;12:939–48.
4. Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227–32.
5. Dell’ Antone P. Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects? Med Hypotheses. 2012;79:388–92.
6. Wang Y, Nie F, Ouyang J, Wang X, Ma X. Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:9563–9.
7. Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661–5.
8. Xu WJ, Chen LG, Chen X, Liu YS, Zheng TH, Song JJ, Xu W, Li P, Zhang MQ, Xiao CX, Guleng B, Ren JL. Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK. Neoplasma. 2015;62:872–80.
9. Li X, Lu Y, Lu H, Luo J, Hong Y, Fan Z. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab. Oncotarget. 2015;6:11507–18.
10. Sadeghi RN, Karami-Tehrani F, Salami S. Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:2893–905.
11. Flaveny CA, Griffett K, El-Gendy Bel D, Kazantzis M, Sengupta M, Amelio AL, Chatterjee A, Walker J, Solt LA, Kamenecka TM, Burris TP. Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis. Cancer Cell. 2015;28:42–56.
12. Pucci S, Zonetti MJ, Fisco T, Polidoro C, Bocchinfuso G, Palleschi A, Novelli G, Spagnoli LG, Mazzarelli P. Carnitine palmitoyl transferase-1a (CPT1A): a new tumor specific target in human breast cancer. Oncotarget. 2016.
13. Lee EA, Angka L, Rota SG, Hanlon T, Mitchell A, Hurren R, Wang XM, Gronda M, Boyaci E, Bojko B, Minden M, Sriskanthadevan S, Datti A, Wrana JL, Edginton A, Pawliszyn J, Joseph JW, Quadrilatero J, Schimmer AD, Spagnuolo PA. Targeting mitochondria with avocatin B induces selective leukemia cell death. Cancer Res. 2015;75:2478–88.
14. Linher-Melville K, Zantinge S, Sanli T, Gerstein H, Tsakiridis T, Singh G. Establishing a relationship between prolactin and altered fatty acid beta-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells. BMC Cancer. 2011;11:56.
15. Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J, Boukhali M, Lengrand J, Deshpande V, Selig MK, Ferrone CR, Settleman J, Stephanopoulos G, Dyson NJ, Zoncu R, Ramaswamy S, Haas W, Bardeesy N. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature. 2015;524:361–5.
16. Scott JW, Galic S, Graham KL, Foitzik R, Ling NX, Dite TA, Issa SM, Langendorf CG, Weng QP, Thomas HE, Kay TW, Birnberg NC, Steinberg GR, Kemp BE, Oakhill JS. Inhibition of AMP-activated protein kinase at the allosteric drug-binding site promotes islet insulin release. Chemistry & Biology. 2015;22:705–11.
17. Soreide K, Sund M. Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer. Cancer Lett. 2015;356:281–8.
18. Fritz V, Benfodda Z, Henriquet C, Hure S, Cristol JP, Michel F, Carbonneau MA, Casas F, Fajas L. Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth. Oncogene. 2013;32:5101–10.
19. Klingemann H. Challenges of cancer therapy with natural killer cells. Cytotherapy. 2015;17:245–9.
20. Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the national comprehensive cancer network clinical practice guidelines. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:186–91.
21. Rejiba S, Bigand C, Parmentier C, Hajri A. Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies. Neoplasia. 2009;11:637–50.
22. Loubiere C, Goiran T, Laurent K, Djabari Z, Tanti JF, Bost F. Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells. Oncotarget. 2015;6:15652–61.
23. Hu J, Che L, Li L, Pilo MG, Cigliano A, Ribback S, Li X, Latte G, Mela M, Evert M, Dombrowski F, Zheng G, Chen X, Calvisi DF. Co-activation of AKT and c-MET triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice. Scientific Reports. 2016;6:20484.
24. Li P, Tian W, Ma X. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 2014;13:138.
25. Guo S, Wang Y, Zhou D, Li Z. Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging. Scientific Reports. 2014;4:5959.
26. Li J, Ren S, Piao HL, Wang F, Yin P, Xu C, Lu X, Ye G, Shao Y, Yan M, Zhao X, Sun Y, Xu G. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer. Scientific Reports. 2016;6:20984.